|
Trehu, E G; Isner, J M; Mier, J W et al. (1993) Possible myocardial toxicity associated with interleukin-4 therapy. J Immunother Emphasis Tumor Immunol 14:348-51
|
|
Massarotti, E M; Liu, N Y; Mier, J et al. (1992) Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy. Am J Med 92:693-7
|
|
Sauter, N P; Atkins, M B; Mier, J W et al. (1992) Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-alpha therapy for metastatic carcinoma: a case report. Am J Med 92:441-4
|
|
Vachino, G; Gelfand, J A; Atkins, M B et al. (1991) Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes. Blood 78:2505-13
|
|
Snydman, D R; Sullivan, B; Gill, M et al. (1990) Nosocomial sepsis associated with interleukin-2. Ann Intern Med 112:102-7
|
|
Mier, J W; Vachino, G; Klempner, M S et al. (1990) Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects. Blood 76:1933-40
|
